New GLP-1 RA ‘better than semaglutide’ for weight loss in Lancet study
A high dose of a new once-weekly injected GLP-1 receptor agonist has outdone semaglutide for weight loss in a phase III trial. Ecnoglutide, developed in…
Tag: weight
Divine dispute: Uniting Church says telehealth clinic misusing its brand name
Telehealth corporate Eucalyptus is embroiled in a legal battle with the Uniting Church over its online weight loss program Juniper with the church alleging it…
I’d be rich if I had a dollar for every unwanted comment about my weight
Something I’ve struggled with my whole life is my weight. Not because I’m unhappy with my body, but because others seem to be. Let me…
Bariatric surgeons under pressure? Life beyond the $69,000 premiums
Are bariatric surgeons in trouble? Many are facing sky-high premiums fuelled by an apparent rise in patient complaints. And what about the GLP-1s? Will they…
The dismal science returns: How do you make GLP-1 RAs worth taxpayers’ money?
UK Secretary of State for Health and Social Care Wes Streeting. AAP.There are many wondrous things about GLP-1 receptor agonists, not least their capacity to…
Tirzepatide reduces weight more than semaglutide in head-to-head trial of patients without diabetes
Tirzepatide leads to greater weight loss than semaglutide in adults with obesity but without type 2 diabetes, a head-to-head trial suggests. Published in the New…
Call for doctors prescribing semaglutide to refer patients to dietitians
GPs who prescribe semaglutide should be obliged to also refer those patients on to a dietitian for appropriate counselling, Dietitians Australia says. The organisation’s president…
‘They are devastated’: When your patient discovers stopping semaglutide means the weight returns
Semaglutide is a game changer for patients right up until they stop the treatment, when many face the heartbreak of watching the kilos return. That…
Obesity is a disease but not diagnosed with BMI alone, says Lancet Global Commission
BMI can be used to diagnose obesity but only in conjunction with other measures of body fat, according to a landmark international statement. A Lancet…
Pharma pushes for GLP-1 receptor agonist to be listed on the PBS for obesity
Pharmaceutical giant Eli Lilly is readying a PBAC application for tirzepatide, which if successful, would become the first GLP-1 receptor agonist publicly funded for obesity…
